English
中文
¦
English
HOME
Home
ABOUT
Nav
SECTORS
Nav
MASTERPLAN
Nav
ECOSYSTEM
Nav
SERVICE
Nav
EVENT
Nav
MEDIA
Nav
CONTACT
Nav
About BioSpark
Zhang Jian's Medical Legacy
Biopharmaceuticals
Medical Technologies
Food & Nutrition
Consumer Health
Site Plan
3D View
Case Study
Facilities
Features & University Collaborations
Clinical Trials & Animal Test
Talents
Amenities
Permitting Services
Investment and Financing
Incentives
Data Hub
Stuttgart
Munich
Ingolstadt
Berlin
Past Events
文章分类
Insights
News
Mobile-Case study
-Rehn Medical
[ Mobile-Case study ]
2025-10-20
-Devro
[ Mobile-Case study ]
2025-10-20
-BioNTech x Biotheus
[ Mobile-Case study ]
2025-10-20
-Elleair
[ Mobile-Case study ]
2025-10-20
-Novast
[ Mobile-Case study ]
2025-10-20
-Siegfried
[ Mobile-Case study ]
2025-10-20
-EGENS
[ Mobile-Case study ]
2025-10-20
-GENSCIENCES
[ Mobile-Case study ]
2025-10-20
-Sinobiopharma
[ Mobile-Case study ]
2025-10-20
-Genosaber
[ Mobile-Case study ]
2025-10-20
-Symrise
[ Mobile-Case study ]
2025-10-20
-Givaudan
[ Mobile-Case study ]
2025-10-20
-HONSUN
[ Mobile-Case study ]
2025-10-20
-Melaleuca
[ Mobile-Case study ]
2025-10-20
-Kewpie
[ Mobile-Case study ]
2025-10-20
-SHOKKEN
[ Mobile-Case study ]
2025-10-20
-Shanghai Pharma Dongying
[ Mobile-Case study ]
2025-10-20
-Merck
[ Mobile-Case study ]
2025-10-20
Prev
1
Next
About BioSpark
Contact
Privacy Policy
Copyright © Nantong Economic & Technological Development Area Investment Promotion Center Co., Ltd.
Mobile version